2017-4

SUBJECT INDEX 2017
Megakaryocytic emperipolesis / Megakaryositik emperipolez, 370
GATA1 / GATA1, 370
Other
Acute lymphoblastic leukemia / Akut lenfoblastik lösemi, 40, 151, 366
Endocrine / Endokrin, 40
Late effects / Geç yan etkiler, 40
Children / Çocuk, 40
Ankaferd Blood Stopper / Ankaferd Blood Stopper, 93
Shiga-toxigenic Escherichia coli / Shigatoksijenik Escherichia coli, 93
Salmonella / Salmonella, 93
Campylobacter / Campylobacter, 93
Listeria monocytogenes / Listeria monocytogenes, 93
Wernicke’s encephalopathy / Wernicke ensefalopatisi, 99
Thiamine deficiency / Tiamin eksikliği, 99
Pediatric leukemia / Pediatrik lösemi, 99
Hemophilia A / Hemofili A, 113
Intradiploic hematoma / İntradiploik hematom, 113
Coagulopathy / Koagülopati, 113
Intraosseous / İntraosseoz, 113
Bullous / Büllöz, 118
Figurate erythema / Figüre eritem, 118
Myelodysplastic syndrome / Miyelodisplastik sendrom, 118
Sweet’s syndrome / Sweet sendromu, 118
Glucocorticoid receptor gene / Glukokortikoid reseptör geni, 151
BclI and N363S polymorphisms / BclI ve N363S polimorfizmleri, 151
Acute compartment syndrome / Akut kompartman sendromu, 179
Inflammation / Enflamasyon, 179
Immune deficiency / İmmün yetmezlik, 179
Myeloma / Miyelom, 89, 181, 182, 352
Infection / Enfeksiyon, 181
Atlas / Atlas, 181
Fracture / Kırık, 181
Afibrinogenemia / Afibrinojenemi, 183
Bone cysts / Kemik kistleri, 183
Child / Çocuk, 183
Rare / Nadir, 183
Cytogenetic / Sitogenetik, 197
Chronic myeloid leukemia / Kronik miyeloid lösemi, 16, 137, 197
Molecular hematology / Moleküler hematoloji, 197
Life-quality / Yaşam kalitesi, 197
Dasatinib / Dasatinib, 197
Nilotinib / Nilotinib, 137, 197, 362
Immunoregulatory effect / Bağışıklık baskılayıcı etki, 213
Co-culture / Ko-kültür, 213
Mesenchymal stem cells / Mezenkimal kök hücre, 213
T cells / T hücre, 213
Multiple myeloma / Multipl miyelom, 131, 184, 226, 233, 282
Relapse refractory / Relaps refrakter, 233
Bendamustine / Bendamustin, 233
Sticky platelet syndrome / Yapışkan trombosit sendromu, 239
Thrombophilia / Trombofili, 239
Miscarriages / Düşükler, 239
Wolman disease / Wolman hastalığı, 264
Hemophagocytic lymphohistiocytosis /
Hemafagositik lenfohistiyositozis, 264
Hemophagocytosis / Hemofagositoz, 264
Hairy cell leukemia / Saçlı hücreli lösemi, 270, 289, 291
Splenectomy / Splenektomi, 270, 291
Sweet’s syndrome / Sweet’s sendromu, 270
Psychogenic purpura / Psikojenik purpura, 274
Gardner-Diamond syndrome / Gardner-Diamond sendromu, 274
Antidepressant / Antidepresan, 274
Adolescent / Adölesan, 274
Hematopoietic stem and progenitor cells / Hematopoietik stem
ve progenitor hücreler, 280
Stem cell mobilization / Stem hücre mobilizasyonu, 280
Apheresis / Aferez, 280
ISBT 128 / ISBT 128, 280
JACIE / JACIE, 280
Labeling / Etiketleme, 280
Traceability / Takip edilebilirlik, 280
Leukoagglutination / Lökoaglütinasyon, 354
Cold agglutinin / Soğuk aglütinin, 354
Mycoplasma pneumoniae / Mycoplasma pneumoniae, 354
Eosinophilia / Eozinofili, 354
Pseudoleukopenia / Psödolökopeni, 354
Dysfibrinogenemia / Disfibrinojenemi, 356
Liver transplantation / Karaciğer nakli, 356
Subdural hematoma / Subdural hematom, 356
Neuroblastoma / Nöroblastoma, 369
Circulating tumor cells / Dolaşan tümör hücreleri, 369
Metastasis / Metastaz, 369
Myopathy / Miyopati, 376
Lactic acidosis / Laktik asidoz, 376
Sideroblastic anemia / Sideroblastik anemi, 376
T-cell neoplasms / T hücreli neoplazmlar, 378
Non-Hodgkin lymphoma / Hodgkin dışı lenfoma, 207, 378, 381
Oncogenes / Onkogenler, 378
T-cell mediated immunity / T hücre aracılı immünite, 378
Hematopoietic stem cell / Hematopoietik kök hücre, 321
Donor / Donör, 321
Informed consent / Bilgilendirilmiş onam, 321
Audiovisual method / Audovizuel yöntem, 321
Bone marrow transplantation / Kemik iliği nakli, 321
Hidden blood loss / Gizli kan kaybı, 334
Antioxidants / Antioksidanlar, 334
Proanthocyanidin / Proantosiyanidin, 334
Hydrogen water / Hidrojenli su, 334
Monoclonal gammopathy of renal significance / Renal öneme
sahip monoklonal gammopati, 282
Plasma cell disorders / Plazma hücre hastalıkları, 282
Renal involvement / Böbrek tutulumu, 282
Kidney / Böbrek, 282
Cast nephropathy / Kast nefropati, 282
Pathology
TP53 / TP53, 34
Immunohistochemistry / İmmünohistokimya, 34
Chronic lymphocytic lymphoma / Kronik lenfosittik lenfoma, 34
Proliferation centers / Proliferasyon merkezleri, 34
Schistocyte / Şistosit,
thrombotic microangiopathy / trombotik mikroanjiopati, 59
Microscopy / Mikroskop, 59
ADVIA 2120 / ADVIA 2120, 59
Standardization / Standardizasyon, 59
Diagnosis of lymphoma / Lenfoma tanısı, 81
World Health Organization lymphoma classification / Dünya
Sağlık Örgütü lenfoma sınıflaması, 81